Patient engagement and shared decision-making
What do they look like in neurology practice?
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received December 7, 2015
- Accepted January 12, 2016
- First Published March 16, 2016.
Article Versions
- Previous version (March 16, 2016 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Melissa J. Armstrong, MD, MSc,
- Lisa M. Shulman, MD,
- Joseph Vandigo, MBA and
- C. Daniel Mullins, PhD
- Melissa J. Armstrong, MD, MSc,
NONE
NONE
(1) International Parkinson and Movement Disorder Society, speaker honoraria for the 18th International Congresses (2014) (2) American Academy of Neurology, faculty honoraria for the 2014 and 2015 annual meetings
(1) Neurology, Level of Evidence Editorial Board, 2012- current
NONE
(1) Parkinson's Disease Improving Patient Care, Oxford University Press, 2014
NONE
(1) American Academy of Neurology Evidence-Based Medicine Methodology Consultant
NONE
NONE
NONE
(1) Abbvie (2) Insightec
(1) ARHQ, 1K08HS024159-01, PI, 2015-2020 (2) NIH U01 AR057967-01, sub-investigator, 2014-2015
(1) University of Maryland School of Medicine
(1) Parkinson Study Group (2) Huntington Study Group (3) CHDI Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Lisa M. Shulman, MD,
NONE
NONE
NONE
AAN Neurology Now Patient Book Series, Editor-in-Chief, 2007-2016; Neurology Now Magazine, Advisory Board member, 2007-2016
NONE
Parkinson's Disease: A Complete Guide for Patients and Families, Johns Hopkins University Press, 2000, 2007, 2013
NONE
NONE
NONE
NONE
NONE
1) Kyowa Pharmaceuticals, 2) Biotie
NIH U01AR057967-01, PI, 2009-2016
NONE
1) Michael J. Fox Foundation for Parkinsons Research, 2) The Rosalyn Newman Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Joseph Vandigo, MBA and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) AHRQ, R36HS022387-01A1, Principal Investigator, 2014-2015
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- C. Daniel Mullins, PhD
Bayer, Mundipharma, Pfizer
NONE
NONE
NONE
NONE
NONE
NONE
Bayer, Mundipharma, Pfizer
Pfizer
NONE
NONE
Grants as PI from Bayer, Novartis, and Pfizer
Contracts and grants from AHRQ, NHLBI, and PCORI
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Department of Neurology (MJA), University of Florida College of Medicine, Gainesville; Department of Neurology (LMS), University of Maryland School of Medicine, Baltimore; and Pharmaceutical Health Services Research Department (JV, CDM), University of Maryland School of Pharmacy, Baltimore.
- Correspondence to:
Melissa.Armstrong{at}neurology.ufl.edu
Article usage
The Nerve!: Rapid online correspondence
- LETTER RE: Patient engagement and shared decision-making: What do they look like in neurology practice?
- Khichar Purnaram Shubhakaran, MBBS, MD, Dr. S. N. Medical College, Jodhpur, Indiadrkhicharsk@gmail.com
Submitted May 30, 2016
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Daniel Friedman and Dr. Sharon Chiang
► Watch
Related Articles
- No related articles found.